# MED15

## Overview
MED15 is a gene that encodes the protein mediator complex subunit 15, a critical component of the Mediator complex involved in the regulation of transcription by RNA polymerase II. The MED15 protein is characterized by its prion-like domain (PrLD) and KIX domain, which facilitate its role in transcriptional regulation through protein-protein interactions and phase separation dynamics. The PrLD is notable for its ability to undergo amyloid-like transformations, while the KIX domain serves as a docking site for transcription factors, underscoring MED15's role as a versatile mediator in gene expression (Kumar2018KIX; Batlle2021MED15). MED15 is implicated in various biological processes, including beta-cell maturation and lipid metabolism, and its dysregulation is associated with diseases such as type 2 diabetes and cancer (Syring2018The; Kadhim2024Transcriptional).

## Structure
The MED15 protein is a subunit of the Mediator complex, which plays a crucial role in transcription regulation. Structurally, MED15 contains several important domains, including a prion-like domain (PrLD) and a KIX domain. The PrLD is characterized by a glutamine-rich region that can form coiled-coil (CC) structures, which are essential for its amyloid conversion and propagation. This domain can transition from a disordered state to a β-sheet-rich structure during amyloid aggregation, facilitated by hydrophobic residues and coiled-coil interactions (Batlle2021MED15).

The KIX domain, located at the amino terminus, is composed of three α-helices that form hydrophobic pockets, serving as docking sites for transcription factors. This domain is crucial for protein-protein interactions, with the third helix being particularly important (Kumar2018KIX).

MED15 also exhibits intrinsic disorder, allowing it to engage in varied interactions necessary for its function within the Mediator complex. This disorder is primarily due to proline and glutamine residues, which contribute to the protein's ability to form molecular recognition features (MoRFs) during interactions (Cooper2019Med15:). The protein's structure is further characterized by a 'fuzzy' interface, which remains dynamic and polymorphic even upon binding (Cooper2019Med15:).

## Function
MED15, a subunit of the Mediator complex, plays a crucial role in transcription regulation by RNA polymerase II in healthy human cells. It acts as a bridge between gene-specific regulatory proteins and the transcription machinery, facilitating transcriptional activation. MED15 is involved in the formation of nuclear condensates through a mechanism involving liquid-liquid phase separation, which is essential for transcriptional activation and gene expression regulation (Shi2021Formation). These condensates are sensitive to 1,6-Hexanediol and show rapid recovery during fluorescence recovery after photobleaching, indicating their dynamic nature (Shi2021Formation).

MED15 interacts with various transcription factors, including Nkx6-1 and NeuroD1, to regulate the expression of genes necessary for beta-cell maturation and function (Kadhim2024Transcriptional). It is expressed in insulin-producing beta-cells and is crucial for maintaining normal beta-cell function and glucose homeostasis (Kadhim2024Transcriptional). MED15 also plays a role in lipid metabolism by interacting with sterol regulatory element-binding proteins (SREBPs), promoting the expression of lipogenic and cholesterogenic genes (Youn2016Regulation). In the nucleus, MED15 contributes to the structural organization of nuclear condensates, which may facilitate enhancer-promoter interactions and rapid gene activation in response to environmental signals (Shi2021Formation).

## Clinical Significance
Alterations in the expression and function of the MED15 gene have been implicated in several diseases. In pancreatic β-cells, MED15 is essential for maturation and proper insulin production. Loss of MED15 impairs the expression of key β-cell maturation genes, leading to reduced glucose uptake and impaired insulin secretion, which may contribute to the development of glucose intolerance and type 2 diabetes (Kadhim2024Transcriptional).

In cancer, MED15 has been associated with the progression of bladder cancer. Overexpression of MED15 is observed in non-muscle invasive bladder cancer, and its knockdown reduces the proliferation, migration, and invasion of bladder cancer cells, suggesting a role in tumor aggressiveness (Syring2018The). In testicular germ cell tumors, MED15 expression is significantly higher in non-seminomatous germ cell tumors compared to seminomas, indicating its potential as a diagnostic marker and its involvement in tumor progression (Klümper2015Differential).

MED15 also contains a prion-like domain capable of forming amyloid structures, which may have implications for diseases related to protein aggregation. This domain can form amyloid fibrils and propagate in a prion-like manner, potentially affecting transcriptional regulation and contributing to disease (Batlle2021MED15).

## Interactions
MED15, a subunit of the Mediator complex, plays a crucial role in transcription regulation by interacting with various transcription activators. In yeast, MED15 interacts with transcription activators such as Gal4 and Gcn4 through a conserved "fuzzy" binding mechanism. This interaction involves multiple hydrophobic regions within the activation domains of Gal4 and Gcn4, which are characterized by transient and dynamic interactions with MED15's activator-binding domains (ABDs) (Tuttle2021Mediator). The binding is sequence-independent and involves multiple ensemble states, indicating a flexible interaction that enhances transcriptional activation (Tuttle2021Mediator).

In mammalian cells, MED15 is involved in forming nuclear condensates through liquid-liquid phase separation. These condensates are sensitive to 1,6-Hexanediol and involve interactions with other Mediator subunits, such as MED1. The formation of these condensates is regulated by a glutamine-rich intrinsically disordered region and a hydrophobic motif within MED15, which are essential for its phase separation properties (Shi2021Formation). MED15's role in forming these condensates suggests it facilitates interactions between transcription factors and the Mediator complex, potentially enabling rapid gene activation (Shi2021Formation).


## References


[1. (Kumar2018KIX) Vinay Kumar, Mohd Waseem, Nidhi Dwivedi, Sourobh Maji, Angad Kumar, and Jitendra K. Thakur. Kix domain of atmed15a, a mediator subunit of arabidopsis, is required for its interaction with different proteins. Plant Signaling &amp; Behavior, 13(2):e1428514, February 2018. URL: http://dx.doi.org/10.1080/15592324.2018.1428514, doi:10.1080/15592324.2018.1428514. This article has 21 citations.](https://doi.org/10.1080/15592324.2018.1428514)

[2. (Kadhim2024Transcriptional) Alex Z. Kadhim, Ben Vanderkruk, Samantha Mar, Meixia Dan, Katarina Zosel, Eric E. Xu, Rachel J. Spencer, Shugo Sasaki, Xuanjin Cheng, Shannon L. J. Sproul, Thilo Speckmann, Cuilan Nian, Robyn Cullen, Rocky Shi, Dan S. Luciani, Bradford G. Hoffman, Stefan Taubert, and Francis C. Lynn. Transcriptional coactivator med15 is required for beta cell maturation. Nature Communications, October 2024. URL: http://dx.doi.org/10.1038/s41467-024-52801-9, doi:10.1038/s41467-024-52801-9. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-52801-9)

[3. (Batlle2021MED15) Cristina Batlle, Isabel Calvo, Valentin Iglesias, Cian J. Lynch, Marcos Gil-Garcia, Manuel Serrano, and Salvador Ventura. Med15 prion-like domain forms a coiled-coil responsible for its amyloid conversion and propagation. Communications Biology, March 2021. URL: http://dx.doi.org/10.1038/s42003-021-01930-8, doi:10.1038/s42003-021-01930-8. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-021-01930-8)

[4. (Shi2021Formation) Yuanyuan Shi, Jian Chen, Wei-Jie Zeng, Miao Li, Wenxue Zhao, Xing-Ding Zhang, and Jie Yao. Formation of nuclear condensates by the mediator complex subunit med15 in mammalian cells. BMC Biology, November 2021. URL: http://dx.doi.org/10.1186/s12915-021-01178-y, doi:10.1186/s12915-021-01178-y. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12915-021-01178-y)

[5. (Youn2016Regulation) Dou Yeon Youn, Alus M. Xiaoli, Jeffrey E. Pessin, and Fajun Yang. Regulation of metabolism by the mediator complex. Biophysics Reports, 2(2–4):69–77, October 2016. URL: http://dx.doi.org/10.1007/s41048-016-0031-6, doi:10.1007/s41048-016-0031-6. This article has 13 citations.](https://doi.org/10.1007/s41048-016-0031-6)

[6. (Syring2018The) Isabella Syring, Richard Weiten, Tim M�ller, Doris Schmidt, Susanne Steiner, Glen Kristiansen, Stefan M�ller, and J�rg Ellinger. The knockdown of the mediator complex subunit med15 restrains urothelial bladder cancer cells’ malignancy. Oncology Letters, June 2018. URL: http://dx.doi.org/10.3892/ol.2018.9014, doi:10.3892/ol.2018.9014. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2018.9014)

[7. (Tuttle2021Mediator) Lisa M. Tuttle, Derek Pacheco, Linda Warfield, Damien B. Wilburn, Steven Hahn, and Rachel E. Klevit. Mediator subunit med15 dictates the conserved “fuzzy” binding mechanism of yeast transcription activators gal4 and gcn4. Nature Communications, April 2021. URL: http://dx.doi.org/10.1038/s41467-021-22441-4, doi:10.1038/s41467-021-22441-4. This article has 32 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-22441-4)

[8. (Klümper2015Differential) Niklas Klümper, Isabella Syring, Anne Offermann, David Adler, Wenzel Vogel, Stefan C. Müller, Jörg Ellinger, Arne Strauß, Heinz Joachim Radzun, Philipp Ströbel, Johannes Brägelmann, Sven Perner, and Felix Bremmer. Differential expression of mediator complex subunit med15 in testicular germ cell tumors. Diagnostic Pathology, September 2015. URL: http://dx.doi.org/10.1186/s13000-015-0398-6, doi:10.1186/s13000-015-0398-6. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13000-015-0398-6)

[9. (Cooper2019Med15:) David G. Cooper and Jan S. Fassler. Med15: glutamine-rich mediator subunit with potential for plasticity. Trends in Biochemical Sciences, 44(9):737–751, September 2019. URL: http://dx.doi.org/10.1016/j.tibs.2019.03.008, doi:10.1016/j.tibs.2019.03.008. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tibs.2019.03.008)